Author:
Davis Mellar,Fernandez Carlos,Vithalani Nicki,Nicholls Lauren Elizabeth,Digwood Glen
Publisher
Springer International Publishing
Reference377 articles.
1. Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, Legrand SB, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. 2006;14(5):444–53.
2. Palm RF, Jim HSL, Boulware D, Johnstone PAS, Naghavi AO. Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma. Clin Transl Radiat Oncol. 2020;22:22–8.
3. McGee SF, Zhang T, Jonker H, Laurie SA, Goss G, Nicholas G, et al. The impact of baseline Edmonton symptom assessment scale scores on treatment and survival in patients with advanced non-small-cell lung cancer. Clin Lung Cancer. 2018;19(1):e91–e9.
4. Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, et al. Minimal clinically important differences in the Edmonton symptom assessment scale in cancer patients: a prospective, multicenter study. Cancer. 2015;121(17):3027–35.
5. Selby D, Chakraborty A, Myers J, Saskin R, Mazzotta P, Gill A. High scores on the Edmonton symptom assessment scale identify patients with self-defined high symptom burden. J Palliat Med. 2011;14(12):1309–16.